It's a fundamental shift from management to regeneration
But like most other fad diets that focus on a low calorie intake, the grapefruit diet hasn't been proven to be safe or effective
It has an important role to play in various functions of the body
In reality, they may still be in the early stages of treatment
UK considerations NHS and MHRA guidance The UK health authorities have clear positions on weight loss treatments: The NHS offers GLP-1 medications through specialist weight management services for eligible patients MHRA has approved Wegovy, Saxenda, and Mounjaro based on comprehensive safety and efficacy data No GLP-1 patch products have received MHRA approval as weight loss treatments The MHRA has issued warnings about misleading claims in weight loss supplements Cost and access in the UK The financial aspect is a significant consideration for many: NHS provision : Limited availability through specialist weight management services with strict eligibility criteria Private prescriptions : 150-300 monthly, depending on medication and provider Commercial patches : 12-70 monthly, depending on brand and quantity While patches appear less expensive, they lack evidence of effectiveness, making them poor value regardless of price
El Colegio Americano de Cardiologa (ACC), la Sociedad Americana del Corazn (AHA) y la Sociedad de la Obesidad (TOS) definen al sobrepeso como un ndice de masa corporal (IMC) entre 25 y 29,9 kg/m 2 y la obesidad como un IMC igual o superior a 30 kg/m 2 (1)
